Plain-English translation of NCT06030258 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new drug called combined with three other medications — an immunotherapy drug, a chemotherapy drug, and another chemotherapy drug — to treat advanced small cell lung cancer. The study will first figure out the right dose of this medication, then test whether adding it to the standard treatment works better than the standard treatment alone.
Advanced small cell lung cancer is a serious disease with limited treatment options. Researchers believe that this medication may help the body's immune system fight the cancer more effectively when combined with existing treatments, potentially helping patients live longer.
You likely qualify if…
You likely don't qualify if…
The trial has two parts: a dose-finding phase and then an efficacy-testing phase. Participants will receive the study medications either as the new four-drug combination or as the standard three-drug combination (the control group). You would visit the clinic regularly for blood tests, scans, and check-ups to monitor how the treatment is working and to watch for side effects. The exact schedule of visits and duration will be explained by the research team at your screening visit.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China